Risk factors for acquisition of extended-spectrum β-lactamase–producing Escherichia coli in an urban county hospital
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Health Policy,Epidemiology
Reference16 articles.
1. Resistance in Gram-negative bacteria: Enterobacteriaceae;Paterson;Am J Infect Control,2006
2. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region;Winokur;Clin Infect Dis,2001
3. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004;Am J Infect Control,2004
4. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection;Hyle;Arch Intern Med,2005
5. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in enterobacteriaceae bacteraemia: a systematic review and meta-analysis;Schwaber;J Antimicrob Chemother,2007
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended‐Spectrum β‐lactamase producing Enterobacterales (ESBL‐E);Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-12-09
2. Extended-spectrum β-lactamase- producing gram-negative bacterial infections in severely ill COVID-19 patients admitted in a national referral hospital, Kenya;2023-03-29
3. Transfer of Extended Spectrum Cephalosporin Resistant Enterobacteriaceae Among Patients on an HSCT Unit and the Value of Surveillance and Contact Isolation;Transplantation and Cellular Therapy;2023-01
4. Secondary Infections in Critically Ill Patients with COVID-19: A Retrospective Study;Antibiotics;2022-11-11
5. The impact of non-antimicrobial drug agents on the acquisition of ESBL-producing Enterobacterales in non-critical care wards in a German university hospital: an exploratory, matched case–control study;Journal of Antimicrobial Chemotherapy;2021-11-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3